SLDE Q1 2026 Earnings EPS Surges Past Estimates with 174 Beat SHIM Q1 2026 Earnings EPS Misses Estimates as Stock Declines Sharply BioVie Inc Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Development RDN Q1 2026 Earnings EPS Beat Sends Stock Lower Despite Positive Surprise CRVO Q1 2026 Earnings WiderthanExpected Loss as PreClinical Stage Company Reports No Revenue Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio